| Authors: |
Law ZK; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom.; Department of Medicine, National University of Malaysia, Kuala Lumpur, Malaysia (Z.K.L)., Ali A; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom., Krishnan K; Department of Stroke, Nottingham University Hospitals NHS Trust, United Kingdom (K.K., N.S., P.M.B)., Bischoff A; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom., Appleton JP; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom., Scutt P; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom., Woodhouse L; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom., Pszczolkowski S; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom.; Radiological Sciences (S.P., R.A.D.), University of Nottingham, United Kingdom., Cala LA; School of Medicine, University of Western Australia, Perth, Australia (L.A.C.)., Dineen RA; Radiological Sciences (S.P., R.A.D.), University of Nottingham, United Kingdom., England TJ; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom.; NIHR Nottingham Biomedical Research Centre (RD) and Vascular Medicine, Division of Medical Sciences and GEM (T.J.E.), University of Nottingham, United Kingdom., Ozturk S; Department of Neurology, Selcuk University Medical Faculty, Konya, Turkey (S.O.)., Roffe C; Institute for Applied Clinical Studies, Keele University, Staffordshire, Stoke-on-Trent, United Kingdom (C.R.)., Bereczki D; Department of Neurology, Semmelweis University, Budapest, Hungary (D.B.)., Ciccone A; Neurology Unit, Azienda Socio Sanitaria Territoriale di Mantova, Mantua, Italy (A.C.)., Christensen H; Department of Neurology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen (C.O., H.C.)., Ovesen C; Department of Neurology, Bispebjerg and Frederiksberg Hospital, University of Copenhagen (C.O., H.C.).; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Denmark (C.O.)., Bath PM; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom.; Department of Stroke, Nottingham University Hospitals NHS Trust, United Kingdom (K.K., N.S., P.M.B)., Sprigg N; From the Stroke Trials Unit, Division of Clinical Neuroscience (Z.K.L., A.A., A.B., J.P.A., P.S., L.W., S.P., T.J.E., N.S., P.M.B), University of Nottingham, United Kingdom.; Department of Stroke, Nottingham University Hospitals NHS Trust, United Kingdom (K.K., N.S., P.M.B). |
